Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-templated transcription is the fundamental biological process where a specific segment of DNA is copied into RNA by the enzyme RNA polymerase. This process is the first step of gene expression and is essential for the survival, growth, and differentiation of all living organisms, as it produces the messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA) required for protein synthesis. Although 'DNA-templated transcription' is a broad Gene Ontology (GO) term rather than a single molecular target, the machinery that executes this process—most notably DNA-directed RNA polymerases and associated transcription factors—serves as a vital target for various therapeutic agents. In oncology, drugs like Actinomycin D and Lurbinectedin disrupt transcription to kill rapidly dividing cancer cells, while in infectious diseases, antibiotics like Rifampicin selectively target bacterial RNA polymerase to treat infections like tuberculosis. However, because transcription is a universal requirement for cellular function, drugs targeting this process often face significant challenges regarding selectivity and can cause severe systemic side effects.
Inhibition of DNA-directed RNA polymerase activity, blockage of transcription initiation by inhibiting the TFIIH complex, DNA intercalation to prevent strand separation, and induction of RNA polymerase II degradation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-templated transcription (GO:0006351).